UBS Group’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-65,700
| Closed | -$53.5K | – | 8929 |
|
|
2024
Q2 | $53.5K | Buy |
+65,700
| New | +$53.5K | ﹤0.01% | 5498 |
|
|
2023
Q2 | – | Sell |
-12,379
| Closed | -$11.9K | – | 8568 |
|
|
2023
Q1 | $11.9K | Buy |
+12,379
| New | +$11.9K | ﹤0.01% | 6379 |
|
|
2022
Q4 | – | Sell |
-2,657
| Closed | -$6K | – | 9907 |
|
|
2022
Q3 | $6K | Buy |
2,657
+458
| +21% | +$1.03K | ﹤0.01% | 7983 |
|
|
2022
Q2 | $6K | Sell |
2,199
-706
| -24% | -$1.93K | ﹤0.01% | 7704 |
|
|
2022
Q1 | $8K | Sell |
2,905
-2,116
| -42% | -$5.83K | ﹤0.01% | 7661 |
|
|
2021
Q4 | $26K | Buy |
+5,021
| New | +$26K | ﹤0.01% | 6438 |
|
|
2021
Q3 | – | Sell |
-464
| Closed | -$5K | – | 8888 |
|
|
2021
Q2 | $5K | Buy |
+464
| New | +$5K | ﹤0.01% | 7475 |
|